Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beclomethasone HFA vs Placebo and QVAR in Persistent Asthma
NCT03834012Phase 3Withdrawn
- Sponsor
- DMK Pharmaceuticals Corporation
- Start
- Feb 2019
- Primary completion
- Nov 2019
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of beclomethasone dipropionate in asthma, sponsored by DMK Pharmaceuticals Corporation. Planned start Feb 2019; status: withdrawn.
02
Drugs
beclomethasone dipropionate
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03834012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03834012.